Results 31 to 40 of about 938,592 (268)
Identification of novel neutralizing determinants for protection against HCV
Hepatology, EarlyView., 2022 Identification of novel neutralizing determinants for protection against hepatitis C virus. Abstract Background and Aims
HCV evasion of neutralizing antibodies (nAb) results in viral persistence and poses challenges to the development of an urgently needed vaccine.Garazi P. Alzua, Anne F. Pihl, Anna Offersgaard, Rodrigo Velázquez‐Moctezuma, Carlos R. Duarte Hernandez, Elias H. Augestad, Ulrik Fahnøe, Christian K. Mathiesen, Henrik Krarup, Mansun Law, Jannick Prentoe, Jens Bukh, Judith M. Gottwein +12 morewiley +1 more sourceLeveraging corona virus disease 2019 vaccination to promote hepatitis C screening
Hepatology Communications, EarlyView., 2022 Abstract
Health care initiatives, such as hepatitis C virus (HCV) screening, have been greatly overshadowed by the corona virus disease 2019 (COVID‐19) pandemic. However, COVID‐19 vaccination programs also provide an opportunity to engage with a high volume of people in a health care setting.Aaron Vanderhoff, David Smookler, Mia J. Biondi, Scott Enman, Tintin Fuliang, Sana Mahmood, Agustina Crespi, Maria Marquez, Rafique Van Uum, Lucy You, Brett Wolfson‐Stofko, Renee Logan, Erin LeDrew, Hemant Shah, Harry Janssen, Camelia Capraru, Elisa Venier, Jordan J. Feld +17 morewiley +1 more sourceHigh prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany : a prospective screening analysis of 28,809 patients [PDF]
, 2012 Background and Aims: The prevalence of hepatitis C virus (HCV) antibodies in Germany has been estimated to be in the range of 0.4–0.63%. Screening for HCV is recommended in patients with elevated ALT levels or significant risk factors for HCV ...Hintereder, Gudrun, Gudrun Hintereder, Karin Hensel-Wiegel, Stefan Zeuzem, Lehmann, Ralf, Tauber, Rudolf, Vermehren, Johannes, Möckel, Martin, Annemarie Berger, Sarrazin, Christoph, Norbert Haas, Müller, Christian, Elanjimattom, Sandra, Christoph Sarrazin, Johannes Vermehren, Schlosser, Beate, Thomas Berg, Rudolf Tauber, Haas, Norbert, Martin Möckel, Walcher, Felix, Christian Müller, Domke, Diana, Diana Domke, Felix Walcher, Hensel-Wiegel, Karin, Berger, Annemarie, Berg, Thomas, Beate Schlosser, Zeuzem, Stefan, Sandra Elanjimattom, Ralf Lehmann, Berger Annemarie, Müller Christian, Lehmann Ralf, Zeuzem Stefan, Domke Diana, Walcher Felix, Möckel Martin, Hintereder Gudrun, Vermehren Johannes, Berg Thomas, Sarrazin Christoph, Tauber Rudolf, Schlosser Beate, Hensel-Wiegel Karin, Elanjimattom Sandra, Haas Norbert +47 morecore +2 more sourcesLipid metabolism and HCV infection [PDF]
, 2010 Chronic infection by hepatitis C virus (HCV) can lead to severe liver disease and is a global healthcare problem. The liver is highly metabolically active and one of its key functions is to control the balance of lipid throughout the body.Boulant, Steeve, Paul Targett-Adams, Targett-Adams, Paul, Douglas, Mark W., McLauchlan, John, Steeve Boulant, John McLauchlan, Mark W. Douglas, Targett-Adams, Douglas, McLauchlan, Boulant +11 morecore +1 more sourceResponse prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms [PDF]
, 2011 Background: High baseline levels of IP-10 predict a slower first phase decline in HCV RNA and a poor outcome following interferon/ribavirin therapy in patients with chronic hepatitis C.Askarieh Galia, Neumann, A.U. (Avidan), Söderholm, Jonas,, Magnus Lindh, Avidan U Neumann, Stephanie Bibert, Soderholm, J, Askarieh, Galia,, Romero, A. (Ana), Group, DITTO-HCV Study, Jean-Michel Pawlotsky, Lindh, M., Negro, F, Söderholm, J., Lindh, M, Missale, Gabriele, Lagging, Martin,, Askarieh, G., Haagmans, Bart L, Romero, Ana, Hellstrand, K. (Kristoffer), Bochud Pierre-Yves, Lagging, Martin, Romero, A, null null, Söderholm Jonas, Haagmans, Bart L., Neumann, AU (Avidan), Gabriele Missale, Ferrari, C., Negro, F., Pawlotsky, J.M., Lindh Magnus, Negro Francesco, Avidan U. Neumann, Pierre-Yves Bochud, Lindh, Magnus, Johan Westin, Zeuzem Stefan, Lindh, M. (Magnus), Missale Gabriele, Bochud, Pierre Yves, Bibert, S., Bochud, P.Y., Galia Askarieh, Lagging Martin, Ferrari Carlo, Bibert, Stephanie, Hellstrand, Kristoffer, Zeuzem, S., Neumann, Avidan U., Haagmans, B.L., DITTO-HCV Study Group, Neumann, A.U., Lindh, Magnus,, Francesco Negro, Westin, J., Söderholm, J. (Jonas), Zeuzem, S. (Stefan), Söderholm, Jonas, Ferrari, Carlo, Martin Lagging, Neumann Avidan U., Zeuzem, Stefan, Neumann, Avidan U, Zeuzem, S, Hellstrand Kristoffer, Westin, Johan, Bart L Haagmans, Romero, A., Lagging, M. (Martin), Hellstrand, K., Haagmans, Bart, Bibert Stephanie, Hellstrand, K, Bart L. Haagmans, Missale, G. (Gabriele), Pawlotsky, Jean Michel, Pawlotsky, Jean-Michel, Ferrari, C. (Carlo), Carlo Ferrari, Bochud, P-Y. (Pierre-Yves), Haagmans Bart L., Askarieh, G, Lagging, M., Missale, G., Stefan Zeuzem, Kristoffer Hellstrand, Ferrari, C, Westin, J. (Johan), Askarieh, Galia, Bibert, S, Lagging, M, Westin, Johan,, Hellstrand, Kristoffer,, Westin, J, Haagmans, B.L. (Bart), Romero Ana, Jonas Söderholm, Pawlotsky Jean-Michel, Westin Johan, Askarieh, G. (Galia), Negro, Francesco, Bochud, PY, Bochud, Pierre-Yves, Pawlotsky, JM, Pawlotsky, J-M. (Jean-Michel), Missale, G, Romero, Ana,, Ana Romero +109 morecore +1 more sourceA multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants [PDF]
, 2010 Variants resistant to compounds specifically targeting HCV are observed in clinical trials. A multi-variant viral dynamic model was developed to quantify the evolution and in vivo fitness of variants in subjects dosed with monotherapy of an HCV protease ...Stefan Zeuzem, Randle, John C. R., Randle John C. R., Lin, Chao, Kwong Ann D., Bambang S Adiwijaya, John C. R. Randle, Sarrazin, Christoph, Paul R. Caron, Herrmann Eva, Zeuzem Stefan, Christoph Sarrazin, Garg Varun, Kieffer, Tara, Brian Hare, Hare, Brian, Varun Garg, Lin Chao, Kieffer Tara, Herrmann, Eva, Caron, Paul R., Kwong, Ann D., Tara Kieffer, Ann D Kwong, Sarrazin Christoph, Chao Lin, Bambang S. Adiwijaya, Adiwijaya, Bambang S., Hare Brian, Paul R Caron, Caron Paul R., Garg, Varun, Eva Herrmann, Ann D. Kwong, John C R Randle, Adiwijaya Bambang S., Zeuzem, Stefan +36 morecore +2 more sourcesAASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
, 2022 Hepatology, EarlyView.Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro +6 morewiley +1 more sourceCellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy [PDF]
, 2010 Background: Hepatitis C virus (HCV) infection is a major cause of morbidity in HIV infected individuals. Coinfection with HIV is associated with diminished HCV-specific immune responses and higher HCV RNA levels.Battegay, Manuel, E. Hammond, Keiser, O., G. Harcourt, P. Klenerman, Hoffmann, M, Furrer, H, Hirschel, Bernhard, Hammond, E., Swiss HIV Cohort Study,, E. Bernasconi, Rohrbach, J, Battegay, M., Harcourt, Gillian, Gorgievski, Meri, Swiss HIV Cohort Study, ., M. Gorgievski, H. F. Gunthard, Rauch, A, Robinson, N., Robinson, Nicola, Klenerman, P., Hammond, E, Furrer, Hansjakob, Telenti, Amalio, M. Hoffmann, Rohrbach, J., Telenti, A., Robinson, N, Günthard, H F, null null, Keiser, O, Hammond, Emma, Battegay, M, J. Rohrbach, Hirschel, B., Bernasconi, E., Gaudieri, S, H. Furrer, Günthard, Huldrych F, Gaudieri, S., O. Keiser, Hoffmann, Matthias, Hammond, E.L., Harcourt, G., Harcourt, G, S. Gaudieri, A. Rauch, Klenerman, Paul, N. Robinson, Gorgievski, M., Bernasconi, E, Günthard Huldrych, F., Klenerman, P, Rauch, A., A. Telenti, Bernasconi, Enos, M. Battegay, Telenti, A, Keiser, Olivia, Gunthard, Huldrych F., B. Hirschel, Gunthard, H. F., Hirschel, Bernard, Furrer, H., Rauch, Andri, Hoffmann, M., Günthard, H.F., Rohrbach, Janine, Hirschel, B, Gaudieri, Silvana, Gorgievski, M, Rohrbach J, Battegay M, Hammond E, Gaudieri S, Klenerman P, Gorgievski M, Rauch A, Harcourt G, Telenti A, Hoffmann M, Bernasconi E, Keiser O, Furrer H, Hirschel B, Robinson N, Günthard HF +87 morecore +2 more sourcesMost common HCV genotypes in patients from north-eastern Croatia [PDF]
Acta Medica Academica, 2014 Objective. The aims of this study were to determine the HCV-RNA
viral load, genotype distribution, risk factors and symptoms of HCVRNA positive viral load in HCV antibody-positive patients from
north-eastern Croatia. Materials and methods. From January Magdalena Perić, Zinka Bošnjak, Snježana Džijan, Bojan Šarkanj, Jerko Barbić, Ivana Roksandić Križan, Nataša Ružman, Vedran Bertić, Dubravka Vuković +8 moredoaj +1 more source